PolyPeptide Group

PolyPeptide is a global Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of peptide-based active pharmaceutical ingredients (APIs) and oligonucleotides. Serving pharmaceutical and biotech customers worldwide, the company supports the creation of therapies for metabolic diseases, cancer, and neurological disorders, contributing to the health of millions of patients through deep technical expertise and GMP-quality production.